The Japanese government will add Moderna’s bivalent vaccine adapted to the BA.4/BA.5 Omicron variants to its COVID-19 booster program, effective November 28, according to a health ministry notification.In the notification dated November 8, the ministry also said that Novavax’s COVID-19…
To read the full story
Related Article
- Moderna’s BA.4/5 COVID Booster Nabs Special Approval in Japan
November 1, 2022
REGULATORY
- Pharma Urges Pricing Rewards to Bolster Japan’s Drug Discovery Strength
September 24, 2026
- New Digital Minister Furukawa Pledges Push for Healthy Longevity
September 24, 2026
- MHLW Eyes Higher Long-Term Care Premiums for Wealthier Seniors
September 24, 2026
- Nippon Ishin’s Urano Named Senior Vice Health Minister in Takaichi Cabinet
September 24, 2026
- Ueno Vows to Advance Drug Innovation, Advanced Medicine in 2nd Term
September 24, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





